Simulations Plus to Participate in the 23rd Annual Craig-Hallum Institutional Investor Conference
For more information about the events or questions about registration, interested parties should reach out to their contacts at Craig-Hallum.
About Simulations Plus, Inc.
Simulations Plus is a global leader in model-informed and AI-accelerated drug development. We create value for our clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through innovative science-based software and consulting solutions. For more information, visit www.simulations-plus.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260521068107/en/
Financial Profiles
Lisa Fortuna
310-622-8251
slp@finprofiles.com
Source: Simulations Plus, Inc.